Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0ZQ0X
|
|||
Drug Name |
PMID27336223-Compound-9
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
CORNELL UNIVERSITY GUDAS, Lorraine J TANG, Xiao-Han OSEI-SARFO, Kwame URVALEK, Aliso
|
|||
Structure |
Download2D MOL |
|||
Formula |
C27H26O3
|
|||
Canonical SMILES |
C1C2CC3CC1CC(C2)(C3)C4=C(C=C5C=CC(=CC5=C4)C6=CC=C(C=C6)C(=O)O)O
|
|||
InChI |
1S/C27H26O3/c28-25-12-22-6-5-21(19-1-3-20(4-2-19)26(29)30)10-23(22)11-24(25)27-13-16-7-17(14-27)9-18(8-16)15-27/h1-6,10-12,16-18,28H,7-9,13-15H2,(H,29,30)
|
|||
InChIKey |
VCQGNUWOMLYNNG-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 107430-66-0
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Retinoic acid receptor gamma (RARG) | Target Info | Agonist | [1] |
Target's Patent Info | Retinoic acid receptor gamma (RARG) | Target's Patent Info | [1] | |
Reactome | Nuclear Receptor transcription pathway | |||
WikiPathways | Vitamin A and Carotenoid Metabolism | |||
Nuclear Receptors in Lipid Metabolism and Toxicity | ||||
Mesodermal Commitment Pathway | ||||
Endoderm Differentiation | ||||
Nuclear Receptors |
References | Top | |||
---|---|---|---|---|
REF 1 | Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review.Expert Opin Ther Pat. 2016 Aug;26(8):957-71. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.